This page shows the latest oxycodone news and features for those working in and with pharma, biotech and healthcare.
Verdict closely follows rejection of Nektar’s opioid analgesic. The FDA’s Anesthetic and Analgesic Committee has rejected yet another opioid drug – this time Intellipharmaceutics’ extended-release oxycodone tablet Aximiris. ... Aximris was
Meanwhile one company, Purdue Pharma, has become increasingly identified for fuelling the epidemic with its opioid products, especially OxyContin, a timed-release formulation of opioid pain medication oxycodone.
And about making it more difficult to distribute fentanyl and oxycodone-based drugs.
The panel also voted by nine votes to six in favour of approving Pfizer's Troxyca ER (oxycodone/naltrexone) for the sane indication. ... Committee members were swayed by the FDA reviewer's report on Troxyca ER however, which concluded that it was
The dangers come from prescriptions opioids such as morphine, codeine, methadone and oxycodone as well as illicit opioids like heroine and heroin/fentanyl mixes.
is also heating up as additional potential competitors include the fentanyl transdermal system IONSYS developed by Johnson and Johnson and MoxDuo, an orally administered combination of morphine and oxycodone being developed
More from news
Approximately 2 fully matching, plus 21 partially matching documents found.
A landmark ruling by a judge in Oklahoma, USA awarded the state record damages of $572m (£468m) from Johnson &Johnson (J&J), the manufacturer of synthetic opioids like oxycodone and fentanyl
The licence is for tamper resistant oxycodone (marketed in the US since 2010) and an oxycodone/naloxone combination marketed in Europe since 2009.
34. ††QRxPharma / Paladin Labs. Licence. MoxDuo IR, fixed dose morphine and oxycodone for pain (NDA filed).
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...